Live Breaking News & Updates on Medsafe For Their Vaccine Against

Press Release – Joint Press Release
Pfizer New Zealand and BioNTech today welcomed the drug safety regulator Medsafe in New Zealand granting Provisional Consent for their COVID-19 mRNA vaccine COMIRNATY. Pfizer is the Market Authorisation Holder in New Zealand. The distribution of the …
Pfizer and BioNTech Achieve Approval by Medsafe For Their Vaccine Against COVID-19
New Zealand drug safety regulator Medsafe, approves supply of COVID-19 mRNA vaccine
COMIRNATY™ to New Zealand.
Pfizer & BioNTech are ready to deliver the 1.5 million doses to New Zealand over 2021, allowing for 750,000 New Zealanders to be vaccinated.
Pfizer has a robust and reliable distribution network to deliver our vaccine to New Zealanders over 2021. ....

New Zealand , New Zealanders , Sean Marett , Anne Harris , Fosun Pharma , Ministry Of Health , Bayer Animal Health , Exchange Commission , Zealand Government Immunisation Implementation Advisory Group , Roche Group , Press Release , Joint Press , Provisional Consent , Market Authorisation Holder , Achieve Approval , Medsafe For Their Vaccine Against , New Zealand Government , Immunisation Implementation Advisory Group , Pfizer New Zealand Managing , Chief Business Officer , Chief Commercial Officer , Pfizer News , Annual Report , Looking Information , Factors That May Affect Future , New Technologies ,